Cannabis Report
Home > Boards > US OTC > Biotechs > Oncolix Inc. (ONCX)

LOL, laraz, this is fun. Lets take a look.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
reaper247 Member Profile
 
Followed By 118
Posts 6,982
Boards Moderated 8
Alias Born 10/02/10
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/6/2018 6:05:22 AM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 6/1/2018 3:06:59 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 5/21/2018 6:29:39 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2018 4:24:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/1/2018 6:44:03 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 4/18/2018 3:34:09 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 4/4/2018 3:17:34 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 4/4/2018 3:17:33 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/2/2018 6:01:54 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/2/2018 6:01:54 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 3/23/2018 6:11:00 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 3/23/2018 6:10:59 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 3/21/2018 4:21:58 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/14/2018 4:41:47 PM
Oncolix Sponsors Additional Research with MD Anderson Cancer Center GlobeNewswire Inc. - 1/31/2018 7:30:00 AM
Oncolix Initiates Patient Recruitment of Second Cohort of Prolanta™ Phase 1 Trial in Advanced Ovarian Cancer GlobeNewswire Inc. - 1/8/2018 7:00:00 AM
Oncolix, Inc., Announces Approval for Listing on OTC-QB GlobeNewswire Inc. - 12/18/2017 4:10:00 PM
Oncolix, Inc., Announces Submission of Application for Listing on OTC-QB GlobeNewswire Inc. - 12/6/2017 7:30:00 AM
Oncolix, Inc. Expands Board of Directors with New Appointment GlobeNewswire Inc. - 12/4/2017 7:30:00 AM
A Personal Letter to the Shareholders from Michael T. Redman, CEO of Oncolix, Inc. GlobeNewswire Inc. - 11/29/2017 7:30:00 AM
reaper247   Thursday, 06/14/18 02:32:43 AM
Re: laraz5 post# 17865
Post # of 17909 
LOL, laraz, this is fun. Lets take a look.

Quote:
Its been 865 days since Prolanta has been in phase 1 recruiting status?



Nope, that is incorrect. Oncolix updated their recruitment status in Feb 2018 to reflect the fact that a second dosing group is currently ongoing.
Quote:

Phase 1 a bust?



Nope, that is incorrect. Phase 1 continues to show potential, hence the second round of dosing.

Quote:
In 865 days, Oncolix is yet to furnish a provable verifiable recruit



Nope, that is incorrect. SEC documents show that there were recruits who were dosed and tested.

Just to expand on that for anyone paying attention.

Oncolix is under the scrutiny of both the SEC and the FDA for public statements and filings.

Quote:
Oncolix has not addressed publically who is currently manufacturing Prolanta



Biovectra is the manufacturer for Prolanta. The former CEO of Biovectra, a subsidiary of Mallinckrodt Pharmaceuticals NYSE:MNK is on the ONCX BOD.

Quote:
Now calculate how many shares were sold to Toxic Financers in the last 865 days times the ratio of PPS decline?



We have done this several times.

In the 10Q filed on 8-18-2017 for Q2 ending 6-30-2017 the ONCX O/S is 103,097,783.

In the 10Q filed on 5-14-2018, for Q1 ending 3-31-2018, the ONCX O/S is 104,477,936.

There has been very little dilution here.

We now know why.

Note holders have agreed to not only provide over $1,000,000+ in additional funding, but are deferring interest and equity repayment until April 2019, which ensures that current shareholders are not gonna be diluted until after results of FDA phase 1 dosing of the second group is public for all to see.

They are not converting, they are not dumping.

Anyone claiming otherwise is either posting false information or ignorant of the facts.

Hope that helps.

GLTU, IMO and FWIW.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist